![]() |
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Toxoplasmosis is an infectious disease caused by the parasite Toxoplasma gondii. This infection is often an opportunistic infection in patients who have decreased immunity including malignancy patients undergoing chemotherapy. Malignancy and chemotherapy cause suppression of the spinal cord so that it can cause decreased production of blood cells. Profile and lymphocytes. The design of this study is a cross section with consecutive techniques. The study took place from November 2019 to January 2020 in the Chemotherapy Unit and the Clinical Pathology Laboratory of RSUP DR. M. Djamil Padang with a total sample of 54 people. This research was conducted by detecting anti-T. gondii IgG and IgM using the patient's medical record. The results showed that as many as 74% of malignant patients undergoing chemotherapy at RSUP Dr. M. Djamil Padang experienced toxoplasmosis with the detection of anti-T-gondii IgG in the patient's blood serum. There is no relationship between the decrease in the status of stem neutrophils, neutrophil segments, and lymphocytes with the incidence of toxoplasmosis in malignant patients undergoing chemotherapy at Dr. M. Djamil Hospital (p> 0.05).
![]() |
![]() |
![]() |
![]() |
![]() |